NANOVAE for knee osteoarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests a new treatment called NANOVAE for knee osteoarthritis. It aims to reduce pain and improve knee function by injecting a special substance into the joint.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 75 years old.
- You have moderate knee osteoarthritis (grade II or III).
- Your knee pain is at least moderate (40 on a 100-point scale).
- You have tried standard treatments like weight loss, physical therapy, or anti-inflammatory medicine in the past year.
- Your body mass index (BMI) is under 45.
- You are free from certain health problems like serious heart disease, diabetes out of control, or recent knee surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new stem cell treatment injected into the knee to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be an option for those who have had persistent knee pain for more than six months.
This study tests a new medicine called NPNP-001 for people with knee osteoarthritis who have not gotten enough relief from other treatments. The medicine is given as an injection into the knee to see if it can reduce pain and improve function.
This trial tests a new injectable filler called ALLOHEAL, injected directly into the knee joint to reduce pain and improve function in people with knee osteoarthritis. The filler is designed to cushion the knee joint and may help reduce pain and stiffness.
This study tests whether a small device that stimulates a nerve in your ear can help reduce knee pain caused by osteoarthritis. If you join, you'll be asked to stop taking your current knee pain medicines during the trial, but you can use a safe rescue medicine (acetaminophen/paracetamol) if needed.
This trial studies changes in joint fluid before and after a procedure called genicular artery embolization (GAE) for knee osteoarthritis. It aims to understand how the procedure works to reduce pain and improve knee function.
This trial tests a new knee injection called MAG200. It may reduce knee pain and make daily activities easier.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.